News

Video

ASCRS 2024: Artificial Intelligence in MIGS data

At the 2024 ASCRS meeting, David M. Lubeck detailed highlights from his presentations on the minimally invasive glaucoma surgery (MIGS) space.

At the 2024 ASCRS meeting, David M. Lubeck, MD, a refractive surgeon and glaucoma specialist from Chicago, Illinois detailed highlights from the meeting, including his presentations on the minimally invasive glaucoma surgery (MIGS) space, the need for artificial intelligence (AI) to offset the limitations of "human intelligence," and the long-lasting impact of canaloplasty procedures.

Video Transcript:

Editor's note: The below transcript has been lightly edited for clarity.

David M. Lubeck, MD:

I am David Lubeck, from Chicago. I'm speaking to you on the last day of the 2024 ASCRS in Boston. This has been a very busy meeting. I've been unexpectedly busy and focused primarily on MIGS and within MIGS, the canaloplasty space.

My three paper presentations, two of them were various aspects of the iTrack global data registry. The registry has become a very important part of my thinking, about not only canaloplasty, but the entire MIGS space. For this procedure, it is now the largest single data set, which has begun prospectively and is generating more and more data and sub data sets, which previously we didn't have. And so we were mostly working on conjecture, and theory.

We're at the point that our human intelligence, or HI, is almost no longer able to sift and sort and make the best sense of the data that we're getting. The session yesterday afternoon, when all these MIGS papers were being presented. Everything, different procedures, combined procedures, various scenarios, different surgeons, all had fairly similar results. So, pressure reductions of between 20 to 30%, medication reduction by at least 50%, but not always to zero. Didn't matter the paper or the topic, the data sets were almost almost interchangeable. So, I would like to see somebody build an AI engine, which is going to be specifically focused on MIGS procedures, and then the analysis of these larger data sets to give us much more nuanced and specific information about treatment paradigms in this space.

The things that are surprising to me, again, canaloplasty–I do mostly canaloplasty for a number of reasons. I'm surprised now at the longevity of effect. There's data at now 6 and 7 years out that it is still providing effective pressure lowering. Specifically in this last session, the most impressive thing to me, or the thing that surprised me, was that one presenter showed a study where up to four MIGS procedures were done in combination, in the same procedure. And the results of four surgeries was not that much better than one or two or three. So there's so much we don't understand that, again, I don't think as human intelligence, we're getting right yet.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.